David Kerrigan

Founder @Semapen Uk

Chester, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2022 — Present

Founder @Semapen Uk

View department →

Chester, GB

GLP1 drugs like Wegovy and Mounjaro are transforming obesity care. The Semapen team have created (and registered with the CQC) a scalable, medically-supervised, remote digital prescribing and monitoring programme using GLP1 drugs. Unlike the online pharmacy cowboys, our core values are informed consent, patient safety, excellent long-term outcomes and responsible prescribing.

EDUCATION

1987 — 1992

The University of Sheffield

Doctor of Medicine (MD), Medicine

N/A

University of Liverpool

MBChB, Medicine

SKILLS

SurgeonsPatient SafetyLaparoscopic SurgeryBoard CertifiedMedical ResearchHealthcare ManagementSurgeryCustomer ServiceBariatricsTreatmentHospitalsClinical TrialsCancerTrainingClinical ResearchLeadershipDiabetesMedical EducationAdvanced Laparoscopic SurgeryBariatric SurgeryHealth EducationResearchGeneral SurgeryHealth PromotionEpidemiologySurgical TrainingHealthcareInternal MedicinePublic HealthMedicine

ABOUT DAVID KERRIGAN

My ambition as a doctor, teacher and a responsible businessman is to create a service…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

David Kerrigan — Founder at Semapen Uk in Chester, GB | Unifers